Clindamycin Phosphate NDC 50090-5958

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-5958Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-5958Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-5958-0	50090595800	1 TUBE in 1 CARTON (50090-5958-0) / 30 g in 1 TUBEMarketed from Apr 7, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clindamycin Phosphate
Generic name (nonproprietary): clindamycin phosphate usp, 1%
Active ingredients: Clindamycin phosphate — 10 mg/g
Dosage form: Gel
Route: Topical
Labeler: A-S Medication Solutions
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212438
Marketing start: Mar 15, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers: Product ID 50090-5958_24cdd706-e1a6-461c-a669-91aa2cd74564SPL ID 24cdd706-e1a6-461c-a669-91aa2cd74564SPL set ID 193a4b02-910f-46b2-8b61-25efea694720RxCUI 2676585UNII EH6D7113I8
Pharmacologic class: Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090595800 followed by a unit qualifier and the quantity

Package 50090-5958-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 2, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Clindamycin phosphate gel, 1% is indicated in the treatment of acne vulgaris. In view of the potential for diarrhea, bloody diarrhea and pseudomembranous colitis, the physician should consider whether other agents are more appropriate (see CONTRAINDICATIONS , WARNINGS and ADVERSE REACTIONS ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212438

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212438
Product	Strength	Form · route	Labeler	Product NDC
Clindamycin Phosphateclindamycin phosphate 1%	Clindamycin phosphate 10 mg/g	GelTopical	Preferred Pharmaceuticals Inc.	68788-8423
Clindamycin Phosphateclindamycin phosphate gel usp, 1%	Clindamycin phosphate 10 mg/g	GelTopical	Encube Ethicals, Inc.	21922-027